Dr. Judith Campisi is Senior Staff Scientist, Lawrence Berkeley National Laboratory and Professor at Buck Institute for Aging Research, Novato, CA. Dr. Campisi is a world leading authority in cellular and molecular biology of aging and the effects of senescent cells on their environment.

Dr. John Crown is a Senator of Ireland, Thomas Baldwin Chair in Cancer Research, Dublin City University, and Newman Clinical Research Professor, University College Dublin. Dr. Crown founded Ireland’s first national cancer treatment research group-ICORG, in 1997. ICORG has 283 members including 95% of cancer-treating consultants in Ireland and has now recruited over 3,000 patients on 52 clinical trials, including 1200 patients recruited to 26 breast cancer trials.

Dr. Richard L. Davidson is Executive Director of the Kimmel Cancer Center and Research Professor of Microbiology, Thomas Jefferson University, Philadelphia, PA. Dr. Davidson is renowned for his studies in somatic cell genetics and mechanisms of mutagenesis and carcinogenesis.

Dr. Ethan Dmitrovsky is the Provost and Executive Vice President of the University of Texas M.D. Anderson Cancer Center. Dr. Dmitrovsky conducts clinical and basic research on lung cancer and other malignancies and in particular the role of retinoids in cancer therapy and chemoprevention. His team played a critical role in determining the molecular basis for successful differentiation therapy in acute promyelocytic leukemia.

Dr. Mark Wentland is Professor of Chemistry and Chemical Biology at Rensselaer Polytechnic Institute. Prior to his tenure at Rensselaer, Dr. Wentlland conducted drug discovery research at Sterling Winthrop and his last position was Sterling Winthrop Fellow and Oncology Discovery Co-Chairman. Dr. Wentland has led efforts resulting in the discovery of nine drug candidates, six of which have been advanced to clinical trials.